Literature DB >> 30219855

Elucidating vancomycin-resistant Enterococcus faecium outbreaks: the role of clonal spread and movement of mobile genetic elements.

X Zhou1, M A Chlebowicz1, E Bathoorn1, S Rosema1, N Couto1, M Lokate1, J P Arends1, A W Friedrich1, J W A Rossen1.   

Abstract

Background: Vancomycin-resistant Enterococcus faecium (VREfm) has emerged as a nosocomial pathogen worldwide. The dissemination of VREfm is due to both clonal spread and spread of mobile genetic elements (MGEs) such as transposons.
Objectives: We aimed to combine vanB-carrying transposon data with core-genome MLST (cgMLST) typing and epidemiological data to understand the pathways of transmission in nosocomial outbreaks.
Methods: Retrospectively, 36 VREfm isolates obtained from 34 patients from seven VREfm outbreak investigations in 2014 were analysed. Isolates were sequenced on a MiSeq and a MinION instrument. De novo assembly was performed in CLC Genomics Workbench and the hybrid assemblies were obtained through Unicycler v0.4.1. Ridom SeqSphere+ was used to extract MLST and cgMLST data. Detailed analysis of each transposon and their integration points was performed using the Artemis Comparison Tool (ACT) and multiple blast analyses.
Results: Four different vanB transposons were found among the isolates. cgMLST divided ST80 isolates into three cluster types (CTs); CT16, CT104 and CT106. ST117 isolates were divided into CT24, CT103 and CT105. Within VREfm isolates belonging to CT103, two different vanB transposons were found. In contrast, VREfm isolates belonging to CT104 and CT106 harboured an identical vanB transposon. Conclusions: cgMLST provides a high discriminatory power for the epidemiological analysis of VREfm. However, additional transposon analysis is needed to detect horizontal gene transfer. Combining these two methods allows investigation of both clonal spread as well as the spread of MGEs. This leads to new insights and thereby better understanding of the complex transmission routes in VREfm outbreaks.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30219855     DOI: 10.1093/jac/dky349

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Hospital outbreak caused by linezolid resistant Enterococcus faecium in Upper Austria.

Authors:  Heidrun Kerschner; Adriana Cabal; Rainer Hartl; Sigrid Machherndl-Spandl; Franz Allerberger; Werner Ruppitsch; Petra Apfalter
Journal:  Antimicrob Resist Infect Control       Date:  2019-09-09       Impact factor: 4.887

2.  Increase of vancomycin-resistant Enterococcus faecium strain type ST117 CT71 at Charité - Universitätsmedizin Berlin, 2008 to 2018.

Authors:  Anna Weber; Friederike Maechler; Frank Schwab; Petra Gastmeier; Axel Kola
Journal:  Antimicrob Resist Infect Control       Date:  2020-07-16       Impact factor: 4.887

3.  Challenges in interpretation of WGS and epidemiological data to investigate nosocomial transmission of vancomycin-resistant Enterococcus faecium in an endemic region: incorporation of patient movement network and admission screening.

Authors:  Vanessa Eichel; Sabrina Klein; Carolin Bootsveld; Uwe Frank; Klaus Heeg; Sébastien Boutin; Dennis Nurjadi
Journal:  J Antimicrob Chemother       Date:  2020-07-01       Impact factor: 5.790

4.  Loss of microbial diversity and pathogen domination of the gut microbiota in critically ill patients.

Authors:  Anuradha Ravi; Fenella D Halstead; Amy Bamford; Anna Casey; Nicholas M Thomson; Willem van Schaik; Catherine Snelson; Robert Goulden; Ebenezer Foster-Nyarko; George M Savva; Tony Whitehouse; Mark J Pallen; Beryl A Oppenheim
Journal:  Microb Genom       Date:  2019-09-11

5.  In vitro efficacy of vancomycin combined with fosfomycin against Vancomycin-Resistant Enterococci strains.

Authors:  Gulseren Aktas
Journal:  Pak J Med Sci       Date:  2020 Jan-Feb       Impact factor: 1.088

Review 6.  Enterococcus faecium: from microbiological insights to practical recommendations for infection control and diagnostics.

Authors:  Xuewei Zhou; Rob J L Willems; Alexander W Friedrich; John W A Rossen; Erik Bathoorn
Journal:  Antimicrob Resist Infect Control       Date:  2020-08-10       Impact factor: 4.887

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.